Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms
- PMID: 28700692
- PMCID: PMC5507443
- DOI: 10.1371/journal.pone.0181199
Gallic acid/hydroxypropyl-β-cyclodextrin complex: Improving solubility for application on in vitro/ in vivo Candida albicans biofilms
Abstract
The aim of this study was to increase the solubility of gallic acid (GA) for the treatment of Candida albicans biofilm, which is very difficult to treat and requires high drug concentrations. Cyclodextrins (CDs) were used for this purpose. Complexes were evaluated by phase-solubility studies, prepared by spray drying and characterized by drug loading, scanning electron microscopy (SEM) and differential scanning calorimetry (DSC). The complexes were tested on C. albicans biofilm using in vitro and in vivo models. HPβCD formed soluble inclusion complexes with GA. The percentage of GA in GA/HPβCD was 10.8 ± 0.01%. The SEM and DSC analyses confirmed the formation of inclusion complexes. GA/HPβCD maintained the antimicrobial activity of the pure GA. GA/HPβCD was effective on C. albicans biofilms of 24 and 48h. The in vivo results showed an anti-inflammatory activity of GA/HPβCD with no difference in invading hypha counting among the groups. This study encourages the development of new antifungal agents.
Conflict of interest statement
Figures






Similar articles
-
Encapsulation of gallic acid/cyclodextrin inclusion complex in electrospun polylactic acid nanofibers: Release behavior and antioxidant activity of gallic acid.Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:231-9. doi: 10.1016/j.msec.2016.02.063. Epub 2016 Feb 26. Mater Sci Eng C Mater Biol Appl. 2016. PMID: 27040215
-
Coencapsulation of Ferulic and Gallic acid in hp-b-cyclodextrin.Food Chem. 2015 Oct 15;185:33-40. doi: 10.1016/j.foodchem.2015.03.058. Epub 2015 Mar 24. Food Chem. 2015. PMID: 25952838
-
Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.J Pharm Sci. 1999 Sep;88(9):889-95. doi: 10.1021/js990067o. J Pharm Sci. 1999. PMID: 10479350
-
Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.J Pharm Biomed Anal. 2008 Jul 15;47(3):535-40. doi: 10.1016/j.jpba.2008.02.006. Epub 2008 Feb 15. J Pharm Biomed Anal. 2008. PMID: 18367363 Review.
-
New Perspectives on the Efficacy of Gallic Acid in Cosmetics & Nanocosmeceuticals.Curr Pharm Des. 2018;24(43):5181-5187. doi: 10.2174/1381612825666190118150614. Curr Pharm Des. 2018. PMID: 30657034 Review.
Cited by
-
Ellagic Acid-Cyclodextrin Complexes for the Treatment of Oral Candidiasis.Molecules. 2021 Jan 19;26(2):505. doi: 10.3390/molecules26020505. Molecules. 2021. PMID: 33477918 Free PMC article.
-
Therapeutic potential of flavonoids in gastrointestinal cancer: Focus on signaling pathways and improvement strategies (Review).Mol Med Rep. 2025 Apr;31(4):109. doi: 10.3892/mmr.2025.13474. Epub 2025 Feb 28. Mol Med Rep. 2025. PMID: 40017144 Free PMC article. Review.
-
Synthesis of Gallic Acid-Loaded Chitosan-Grafted-2-Acrylamido-2-Methylpropane Sulfonic Acid Hydrogels for Oral Controlled Drug Delivery: In Vitro Biodegradation, Antioxidant, and Antibacterial Effects.Gels. 2022 Dec 8;8(12):806. doi: 10.3390/gels8120806. Gels. 2022. PMID: 36547330 Free PMC article.
-
Gallic Acid and Diabetes Mellitus: Its Association with Oxidative Stress.Molecules. 2021 Nov 24;26(23):7115. doi: 10.3390/molecules26237115. Molecules. 2021. PMID: 34885698 Free PMC article. Review.
-
Lichen Polyphenolic Compounds for the Eradication of Candida albicans Biofilms.Front Cell Infect Microbiol. 2021 Sep 16;11:698883. doi: 10.3389/fcimb.2021.698883. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34604104 Free PMC article.
References
-
- Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clinical microbiology reviews. 2007;20(1):133–63. doi: 10.1128/CMR.00029-06 - DOI - PMC - PubMed
-
- Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiology. 2009;4(10):1235–7. doi: 10.2217/fmb.09.85 - DOI - PMC - PubMed
-
- Douglas LJ. Candida biofilms and their role in infection. Trends in Microbiology. 2003;11(1):30–6. doi: https://doi.org/10.1016/S0966-842X(02)00002-1 - DOI - PubMed
-
- Bujdáková H. Management of Candida biofilms: state of knowledge and new options for prevention and eradication. Future Microbiology. 2016;11(2):235–51. doi: 10.2217/fmb.15.139 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources